Ironwood Pharmaceuticals Inc (IRWD)
ROA
Obliczenia
|
2023/Q4 (31 gru 2023) |
2023/Q3 (30 wrz 2023) |
2023/Q2 (30 cze 2023) |
2023/Q1 (31 mar 2023) |
2022/Q4 (31 gru 2022) |
2022/Q3 (30 wrz 2022) |
2022/Q2 (30 cze 2022) |
2022/Q1 (31 mar 2022) |
||
|---|---|---|---|---|---|---|---|---|---|
| Zysk netto (ttm) | w tys. USD | -1 002 240 | -952 288 | -917 292 | 181 978 | 175 065 | 167 572 | 173 100 | 527 323 |
| Aktywa razem | w tys. USD | 471 073 | 524 063 | 603 220 | 1 155 280 | 1 100 520 | 1 040 340 | 975 690 | 1 083 380 |
| ROA | -212,76% | -181,71% | -152,07% | 15,75% | 15,91% | 16,11% | 17,74% | 48,67% |
2023/Q4 obliczenia
ROA = Zysk netto (ttm) ÷ Aktywa razem
= $-1 002 240K ÷ $471 073K
= -212,76%
Analiza porównawcza
2023/Q4
Nazwa spółki
Symbol
ROA
Ironwood Pharmaceuticals Inc
IRWD
-212,76%
Amphastar Pharmaceuticals Inc
AMPH
9,09%
Arcus Biosciences Inc
RCUS
-28,04%
Catalyst Pharmaceuticals Inc
CPRX
15,19%
Dynavax Technologies Corp.
DVAX
-0,64%
Harmony Biosciences Holdings Inc
HRMY
15,88%
Ligand Pharmaceuticals, Inc.
LGND
6,63%
Myriad Genetics, Inc.
MYGN
-22,97%
Pacira BioSciences Inc
PCRX
2,66%
Supernus Pharmaceuticals Inc
SUPN
0,10%
Xencor Inc
XNCR
-13,23%